Bum-Yeol Hwang

Title: Innovations of Bum-Yeol Hwang

Introduction

Bum-Yeol Hwang is a notable inventor based in Moraga, California. He has made significant contributions to the field of biotechnology, particularly in the development of adeno-associated viruses (AAV) for therapeutic applications. With a total of four patents to his name, Hwang's work has the potential to impact gene therapy and treatment methodologies.

Latest Patents

Hwang's latest patents focus on variant adeno-associated viruses and methods of using them. One patent provides AAV variants that exhibit a preference for retrograde movement in neurons, which could enhance the delivery of therapeutic agents to target cells. Another patent details infectious recombinant adeno-associated virus (rAAV) virions that comprise a variant capsid protein and a heterologous nucleic acid. This innovation aims to increase resistance to human AAV neutralizing antibodies, thereby improving the efficacy of gene delivery. Additionally, the patents outline methods for delivering a gene product to individuals in need, showcasing the practical applications of his research.

Career Highlights

Hwang has worked with prestigious institutions such as the University of California and the Howard Hughes Medical Institute. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of Hwang's notable coworkers include David V. Schaffer and Melissa A. Kotterman. Their collaborative efforts have likely played a role in advancing the research and development of AAV technologies.

Conclusion

Bum-Yeol Hwang's innovative work in the field of adeno-associated viruses positions him as a key figure in biotechnology. His patents and collaborations reflect a commitment to advancing gene therapy and improving treatment options for various medical conditions.